Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Change in Accured Expenses (2009 - 2021)

Icon's (ICLR) quarterly Change in Accured Expenses came in at -$33.7 million in Q2 2021, up 36.72% year-over-year from -$24.6 million in Q2 2020, and down 94.57% quarter-over-quarter from -$17.3 million in Q1 2021.

Analysis

Icon (ICLR) Change in Accured Expenses (2009 - 2021) Analysis & Trends

Icon (ICLR) has reported Change in Accured Expenses for 13 consecutive years, with -$33.7 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Change in Accured Expenses rose 36.72% year-over-year to -$33.7 million in Q2 2021; TTM through Jun 2021 was -$19.7 million, a 43.6% increase from a year earlier, with the FY2024 full-year figure at -$28.2 million, up 83.28% from the prior year.
  • Change in Accured Expenses was -$33.7 million for Q2 2021 at Icon, down from -$17.3 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $35.2 million in Q2 2018 and troughed at -$56.8 million in Q1 2018.
  • A 5-year average of -$3.1 million and a median of $5.7 million in 2017 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses tumbled 1750.0% in 2017 and surged 437.84% in 2018, its largest moves.
  • Over 5 years, Change in Accured Expenses stood at $4.2 million in 2017, then jumped by 288.44% to $16.4 million in 2018, then sank by 173.96% to -$12.2 million in 2019, then surged by 259.9% to $19.4 million in 2020, then plunged by 273.3% to -$33.7 million in 2021.
  • The last three Change in Accured Expenses figures came in at -$33.7 million (Q2 2021), -$17.3 million (Q1 2021), and $19.4 million (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 45.02 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 18.90 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 25.10 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 3.94 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 83,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -243,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -33.67 Mn
Mar 31, 2021 -17.31 Mn
Dec 31, 2020 19.43 Mn
Sep 30, 2020 11.87 Mn
Jun 30, 2020 -53.22 Mn
Mar 31, 2020 19.71 Mn
Dec 31, 2019 -12.15 Mn
Sep 30, 2019 10.76 Mn
Jun 30, 2019 -27.01 Mn
Mar 31, 2019 16.43 Mn
Dec 31, 2018 16.43 Mn
Sep 30, 2018 7.13 Mn
Jun 30, 2018 35.24 Mn
Mar 31, 2018 -56.79 Mn
Dec 31, 2017 4.23 Mn
Sep 30, 2017 -2.11 Mn
Jun 30, 2017 -18.01 Mn
Mar 31, 2017 22.57 Mn
Dec 31, 2016 10.11 Mn
Sep 30, 2016 -114,000.00